Pasternak Andy 4
4 · Context Therapeutics Inc. · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Pasternak Andy
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-12+138,900→ 138,900 totalExercise: $0.65Exp: 2035-06-11→ Common Stock (138,900 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer.